Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Kim Forest Enterprise Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -77.22%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Kim Forest Enterprise Co's 3-Year ROIIC % or its related term are showing as below:
TPE:6645's 3-Year ROIIC % is ranked worse than 81.37% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.125
vs TPE:6645: -77.22
Kim Forest Enterprise Co (TPE:6645) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Kim Forest Enterprise Co 3-Year ROIIC % Related Terms
Kim Forest Enterprise Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6645 vs TMO, DHR, IDXX: 3-Year ROIIC % Comparison
For the Diagnostics & Research subindustry, Kim Forest Enterprise Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kim Forest Enterprise Co 3-Year ROIIC % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kim Forest Enterprise Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Kim Forest Enterprise Co's 3-Year ROIIC % falls into.
Kim Forest Enterprise Co 3-Year ROIIC % Calculation
Kim Forest Enterprise Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -142.051 (Dec. 2025) - 46.0249033 (Dec. 2022) )
/
( 841.258 (Dec. 2025) - 597.695 (Dec. 2022) )
=
-188.0759033
/
243.563
=
-77.22%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Kim Forest Enterprise Co (TPE:6645) has a 3-Year ROIIC % of -77.22 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Kim Forest Enterprise Co and its competitors. According to the industry distribution chart, Kim Forest Enterprise Co ranks #166 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 81.4%.
Is Kim Forest Enterprise Co's 3-Year ROIIC % too high?
Kim Forest Enterprise Co's current 3-Year ROIIC % is -77.22. Based on the distribution chart, Kim Forest Enterprise Co ranks #166 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Kim Forest Enterprise Co has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kim Forest Enterprise Co's 3-Year ROIIC % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Kim Forest Enterprise Co ranks #166 out of 204 companies for 3-Year ROIIC %. This places Kim Forest Enterprise Co in the lower half of its industry. The industry median 3-Year ROIIC % is 0.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Diagnostics & Research company?
The median 3-Year ROIIC % among Medical Diagnostics & Research companies is 0.13, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Kim Forest Enterprise Co and its competitors. For the Medical Diagnostics & Research industry, the median 3-Year ROIIC % is 0.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kim Forest Enterprise Co's current 3-Year ROIIC % is -77.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kim Forest Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Kim Forest Enterprise Co (TPE:6645) is currently considered Possible Value Trap. The stock's GF Value™ is NT$24.47, compared to a current price of NT$13.35 — trading 45.4% below its estimated fair value. The current 3-Year ROIIC % is -77.22. Kim Forest Enterprise Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Kim Forest Enterprise Co (TPE:6645), the current 3-Year ROIIC % is -77.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kim Forest Enterprise Co (TPE:6645) Overvalued in 2026?
Based on GuruFocus' analysis, Kim Forest Enterprise Co stock appears to be undervalued.
The current stock price of NT$13.35 is trading 45.4% below its estimated GF Value™ of NT$24.47.
GuruFocus considers Kim Forest Enterprise Co to be Possible Value Trap.
Key valuation signals for TPE:6645:
3-Year ROIIC %: -77.22
GF Value™: NT$24.47 vs. price of NT$13.35 (45.4% below fair value)
No single metric tells the full story. See the TPE:6645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kim Forest Enterprise Co Ltd is engaged in providing clinical medical information, genetic testing services, and biological information. It manufactures medical equipment and also produces drug products. The company's equipment includes Desktop microcentrifuge, Desktop large capacity centrifuge, Filter-type absorption spectrometer, Multifunctional spectrometer, and many more. Its reportable segments are Biomedical products which generates key revenue, and the Precision medicine segment. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States of America.
56GF Score
Get the complete analysis for TPE:6645
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6645 has been successfully added to your 
